Sanaz Khanbolooki, Ph.D.
Affiliations: | 2006 | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Oncology, Cell BiologyGoogle:
"Sanaz Khanbolooki"Parents
Sign in to add mentor| David J. McConkey | grad student | 2006 | The University of Texas Graduate School of Biomedical Sciences at Houston | |
| (The transcription factor nuclear factor kappa B (NFkappaB) maintains TRAIL resistance in human pancreatic cancer cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Metwalli AR, Khanbolooki S, Jinesh G, et al. (2010) Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells. Cancer Biology & Therapy. 10: 885-92 |
| Khanbolooki S, Nawrocki ST, Arumugam T, et al. (2006) Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells. Molecular Cancer Therapeutics. 5: 2251-60 |
| Pan X, Yamamoto T, Arumugam T, et al. (2006) SILENCING OF RELA/P65 ENHANCES TRAIL BUT NOT GEMCITABINE MEDIATED APOPTOSIS IN PANCREATIC CANCER CELLS Pancreas. 33: 487-488 |
| Raut CP, Nawrocki S, Lashinger LM, et al. (2004) Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts. Cancer Biology & Therapy. 3: 1217-24 |